Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms

NCT01761968 is registered in ClinicalTrials.gov with Italfarmaco as lead sponsor.

NCT NCT01761968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01761968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms
Lead sponsor
Italfarmaco
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 31, 2013
Completion date
December 31, 2026
Enrollment
90 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative neoplasms